{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:17:22Z","timestamp":1759335442861,"version":"build-2065373602"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["International Orthopaedics (SICOT)"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s00264-025-06645-7","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T02:39:32Z","timestamp":1756867172000},"page":"2415-2421","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Addressing surgical challenges in patients with severe form of osteogenesis imperfecta and with prolonged bisphosphonate treatment: intramedullary sclerosis and technical solutions"],"prefix":"10.1007","volume":"49","author":[{"given":"\u017deljko","family":"Jele\u010d","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dragan","family":"Primorac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vilim","family":"Molnar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darko","family":"Anti\u010devi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,3]]},"reference":[{"key":"6645_CR1","unstructured":"Steiner RD, Pepin MG, Byers PH Osteogenesis Imperfecta. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. Gene Reviews. Seattle: University of Washington; 1993\u20132017"},{"key":"6645_CR2","doi-asserted-by":"publisher","unstructured":"Deguchi M, Tsuji S, Katsura D, Kasahara K, Kimura F, Murakami T (2021) Current Overview of Osteogenesis Imperfecta. Medicina (Kaunas) 57(5):464. https:\/\/doi.org\/10.3390\/medicina57050464","DOI":"10.3390\/medicina57050464"},{"key":"6645_CR3","doi-asserted-by":"publisher","unstructured":"Glorieux FH, Bishop NJ, Plotkin H, Chabot G, Lanoue G, Travers R (1998) Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. N Engl J Med 339(14):947\u2009\u2013\u200952. https:\/\/doi.org\/10.1056\/NEJM199810013391402. PMID: 9753709","DOI":"10.1056\/NEJM199810013391402"},{"key":"6645_CR4","unstructured":"Fleisch H (2000) Bisphosphonates in bone disease. From the laboratory to the patient, 4th edn. Academic"},{"key":"6645_CR5","doi-asserted-by":"crossref","unstructured":"Bishop N, Russell G (2014) Bisphosphonates. In: Shapiro J, Byers P, Glorieux F, Sponseller P (eds) Osteogenesis imperfecta: A translational approach to brittle bone disease. Academic, pp 495\u2013500","DOI":"10.1016\/B978-0-12-397165-4.00053-8"},{"issue":"11","key":"6645_CR6","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1359\/JBMR.040814","volume":"19","author":"CF Munns","year":"2004","unstructured":"Munns CF, Rauch F, Zeitlin L, Fassier F, Glorieux FH (2004) Delayed osteotomy but not fracture healing in pediatric osteogenesis imperfecta patients receiving pamidronate. J Bone Min Res 19(11):1779\u20131786 Epub 2004 Aug 23. PMID: 15476577","journal-title":"J Bone Min Res"},{"issue":"8","key":"6645_CR7","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1002\/jbmr.2486","volume":"30","author":"EA Anam","year":"2015","unstructured":"Anam EA, Rauch F, Glorieux FH, Fassier F, Hamdy R (2015) Osteotomy healing in children with osteogenesis imperfecta receiving bisphosphonate treatment. J Bone Min Res 30(8):1362\u20131368. https:\/\/doi.org\/10.1002\/jbmr.2486Epub 2015 May 10. PMID: 25708939","journal-title":"J Bone Min Res"},{"key":"6645_CR8","doi-asserted-by":"publisher","unstructured":"Hegazy A, Kenawey M, Sochett E, Tile L, Cheung AM, Howard AW (2016) Unusual Femur Stress Fractures in Children With Osteogenesis Imperfecta and Intramedullary Rods on Long-term Intravenous Pamidronate Therapy. J Pediatr Orthop 36(7):757\u2013761. https:\/\/doi.org\/10.1097\/BPO.0000000000000552. PMID: 26090982","DOI":"10.1097\/BPO.0000000000000552"},{"key":"6645_CR9","doi-asserted-by":"publisher","unstructured":"Trejo P, Fassier F, Glorieux FH, Rauch F (2017) Diaphyseal femur fractures in osteogenesis imperfecta: characteristics and relationship with bisphosphonate treatment. J Bone Min Res 32(5):1034\u20131039. https:\/\/doi.org\/10.1002\/jbmr.3071. Epub 2017 Feb 28. PMID: 28019684.","DOI":"10.1002\/jbmr.3071"},{"key":"6645_CR10","doi-asserted-by":"publisher","unstructured":"Vuorimies I, M\u00e4yr\u00e4np\u00e4\u00e4 MK, Valta H, Kr\u00f6ger H, Toiviainen-Salo S, M\u00e4kitie O (2017) Bisphosphonate Treatment and the Characteristics of Femoral Fractures in Children With Osteogenesis Imperfecta. J Clin Endocrinol Metab 102(4):1333\u20131339. https:\/\/doi.org\/10.1210\/jc.2016-3745. PMID: 28323993","DOI":"10.1210\/jc.2016-3745"},{"key":"6645_CR11","doi-asserted-by":"publisher","unstructured":"Rauch F, Glorieux FH (2004) Osteogenesis imperfecta Lancet 363(9418):1377\u20131385. https:\/\/doi.org\/10.1016\/S0140-6736(04)16051-0. PMID: 15110498","DOI":"10.1016\/S0140-6736(04)16051-0"},{"key":"6645_CR12","doi-asserted-by":"publisher","unstructured":"Abrahamsen B (2010) Adverse effects of bisphosphonates. Calcif Tissue Int 86(6):421\u2013435. https:\/\/doi.org\/10.1007\/s00223-010-9364-1","DOI":"10.1007\/s00223-010-9364-1"},{"key":"6645_CR13","doi-asserted-by":"publisher","unstructured":"Gehrke B, Alves Coelho MC, Brasil d\u2019Alva C, Madeira M (2023) Long-term consequences of osteoporosis therapy with bisphosphonates. Arch Endocrinol Metab 68:e220334. https:\/\/doi.org\/10.20945\/2359-4292-2022-0334","DOI":"10.20945\/2359-4292-2022-0334"},{"key":"6645_CR14","doi-asserted-by":"publisher","unstructured":"Whyte M, Wenkert D, Clements K, McAlister WH, Mumm S (2003) Bisphosphonate-Induced Osteopetrosis. N Engl J Med. 349:457\u2013463. https:\/\/doi.org\/10.1056\/NEJMoa023110. PMID: 12890844","DOI":"10.1056\/NEJMoa023110"},{"key":"6645_CR15","doi-asserted-by":"publisher","unstructured":"Lim CT, Setiobudi T, Das De S (2012) Femoral canal obliteration secondary to prolonged alendronate use: a case report. J Orthop Surg (Hong Kong) 20(1):115\u2013117. https:\/\/doi.org\/10.1177\/230949901202000125. PMID: 22535826","DOI":"10.1177\/230949901202000125"},{"key":"6645_CR16","doi-asserted-by":"publisher","unstructured":"Vasanwala RF, Sanghrajka A, Bishop NJ, H\u00f6gler W (2016) Recurrent proximal femur fractures in a teenager with osteogenesis imperfecta on continuous bisphosphonate therapy: are we overtreating?? J Bone Min Res 31(7):1449\u20131454. https:\/\/doi.org\/10.1002\/jbmr.2805Epub 2016 Mar 14. PMID: 26845496","DOI":"10.1002\/jbmr.2805"},{"key":"6645_CR17","doi-asserted-by":"publisher","unstructured":"Fassier F (2017) Fassier-Duval telescoping system: How I do it? J Pediatr Orthop (Suppl 2):S46-S51. https:\/\/doi.org\/10.1097\/BPO.0000000000001024. PMID: 28799995","DOI":"10.1097\/BPO.0000000000001024"},{"key":"6645_CR18","doi-asserted-by":"publisher","unstructured":"Rapoport M, Bober MB, Raggio C, Wekre LL, Rauch F, Westerheim I, Hart T, van Welzenis T, Mistry A, Clancy J, Booth L, Prince S, Semler O (2023) The patient clinical journey and socioeconomic impact of osteogenesis imperfecta: a systematic scoping review. Orphanet J Rare Dis 18(1):34. https:\/\/doi.org\/10.1186\/s13023-023-02627-3","DOI":"10.1186\/s13023-023-02627-3"},{"key":"6645_CR19","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/978-3-030-42527-2_7","volume-title":"Osteogenesis imperfecta. A case-based guide to surgical decision-making and care","author":"RW Kruse","year":"2020","unstructured":"Kruse RW, Franzone JM (2020) Surgical principles in treating osteogenesis imperfecta (Chap. 7). In: Kruse RW (ed) Osteogenesis imperfecta. A case-based guide to surgical decision-making and care. Springer nature, Cham Swiss, pp 79\u2013109"},{"key":"6645_CR20","doi-asserted-by":"publisher","unstructured":"Almeida Da Silva LC, Kaymaz B, Hori Y, Montufar Wright PE, Rogers KJ, Trionfo A, Howard JJ, Bowen JR, Shrader MW, Miller F (2023) Bone alterations of pamidronate therapy in children with cerebral palsy complicating orthopedic management. J Pediatr Orthop B. https:\/\/doi.org\/10.1097\/BPB.0000000000001136. Epub ahead of print. PMID: 37811568","DOI":"10.1097\/BPB.0000000000001136"},{"key":"6645_CR21","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/978-3-030-42527-2_11","volume-title":"Osteogenesis imperfecta. A case-based guide to surgical decision-making and care","author":"D Anticevic","year":"2020","unstructured":"Anticevic D (2020) Osteogenesis imperfecta in the tibia and ankle (Chap. 11). In: Kruse RW (ed) Osteogenesis imperfecta. A case-based guide to surgical decision-making and care. Springer nature, Cham Swiss, pp 183\u2013202"},{"key":"6645_CR22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11832-012-0383-5","volume":"6","author":"S Chilbule","year":"2012","unstructured":"Chilbule S, Madhuri V (2012) Complications of pamidronate therapy in paediatric osteoporosis. J Child Orthop 6:37\u201343. https:\/\/doi.org\/10.1007\/s11832-012-0383-5Epub 2012 Jan 29. PMID: 23450233; PMCID: PMC3303013","journal-title":"J Child Orthop"},{"key":"6645_CR23","doi-asserted-by":"publisher","unstructured":"Russell RG, Rogers MJ, Frith JC, Luckman SP, Coxon FP, Benford HL, Croucher PI, Shipman C, Fleisch HA (1999) The pharmacology of bisphosphonates and new insights into their mechanisms of action. J Bone Miner Res 14 Suppl 2:53\u201365. https:\/\/doi.org\/10.1002\/jbmr.5650140212. PMID: 10510215","DOI":"10.1002\/jbmr.5650140212"},{"key":"6645_CR24","doi-asserted-by":"publisher","unstructured":"Glorieux FH (2008) Osteogenesis imperfecta. Best Pract Res Clin Rheumatol 22(1):85\u2013100. https:\/\/doi.org\/10.1016\/j.berh.2007.12.012. PMID: 18328983","DOI":"10.1016\/j.berh.2007.12.012"},{"issue":"10028","key":"6645_CR25","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/S0140-6736(15)00728-X","volume":"387","author":"A Forlino","year":"2016","unstructured":"Forlino A, Marini JC, Osteogenesis imperfecta (2016) Lancet 387(10028):1657\u20131671. https:\/\/doi.org\/10.1016\/S0140-6736(15)00728-X. Epub 2015 Nov 3. PMID: 26542481; PMCID: PMC738488","journal-title":"Lancet"}],"container-title":["International Orthopaedics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00264-025-06645-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00264-025-06645-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00264-025-06645-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T07:32:06Z","timestamp":1759303926000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00264-025-06645-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,3]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["6645"],"URL":"https:\/\/doi.org\/10.1007\/s00264-025-06645-7","relation":{},"ISSN":["0341-2695","1432-5195"],"issn-type":[{"type":"print","value":"0341-2695"},{"type":"electronic","value":"1432-5195"}],"subject":[],"published":{"date-parts":[[2025,9,3]]},"assertion":[{"value":"29 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. Our work is approved by the Ethics Committee of the hospital (Register number 20\/19-I).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}